A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment
Vishwanathan, Karthick, SanchezâSimon, Inmaculada, Keam, Bhumsuk, Penel, Nicolas, MiguelâLuken, Maria, Weilert, Doris, Mills, Andrew, Marotti, Marcelo, Johnson, Martin, Ravaud, AlainVolume:
8
Journal:
Pharmacology Research & Perspectives
DOI:
10.1002/prp2.613
Date:
August, 2020
File:
PDF, 1.51 MB
2020